Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2012, Article ID 723407, 4 pages
http://dx.doi.org/10.1155/2012/723407
Case Report

Respiratory Syncytial Virus Pneumonia Treated with Lower-Dose Palivizumab in a Heart Transplant Recipient

1Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA
2Division of Infectious Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA
3Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA

Received 3 October 2011; Accepted 20 October 2011

Academic Editors: K.-R. Chiou and T. Kasai

Copyright © 2012 J. L. Grodin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. B. Hall, “Respiratory syncytial virus and parainfluenza virus,” The New England Journal of Medicine, vol. 344, no. 25, pp. 1917–1928, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. M. Chakinala and M. J. Walter, “Community acquired respiratory viral infections after lung transplantation: clinical features and long-term consequences,” Seminars in Thoracic and Cardiovascular Surgery, vol. 16, no. 4, pp. 342–349, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. R. Falsey, P. A. Hennessey, M. A. Formica, C. Cox, and E. E. Walsh, “Respiratory syncytial virus infection in elderly and high-risk adults,” The New England Journal of Medicine, vol. 352, no. 17, pp. 1749–1759, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. F. López-Medrano, J. M. Aguado, M. Lizasoain et al., “Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study,” Transplantation, vol. 84, no. 7, pp. 851–856, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. Humar, D. Kumar, T. Mazzulli et al., “A surveillance study of adenovirus infection in adult solid organ transplant recipients,” American Journal of Transplantation, vol. 5, no. 10, pp. 2555–2559, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. P. Embrey and L. J. Geist, “Influenza A pneumonitis following treatment of acute cardiac allograft rejection with murine monoclonal anti-CD3 antibody (OKT3),” Chest, vol. 108, no. 5, pp. 1456–1459, 1995. View at Google Scholar · View at Scopus
  7. J. T. Sinnott, J. P. Cullison, M. S. Sweeney, M. Hammond, and D. A. Holt, “Respiratory syncytial virus pneumonia in a cardiac transplant recipient,” Journal of Infectious Diseases, vol. 158, no. 3, pp. 650–651, 1988. View at Google Scholar · View at Scopus
  8. N. Berbari, D. H. Johnson, and B. A. Cunha, “Respiratory syncytial virus pneumonia in a heart transplant recipient presenting as fever of unknown origin diagnosed by gallium scan,” Heart and Lung, vol. 24, no. 3, pp. 257–259, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. K. L. Hicks, R. F. Chemaly, and D. P. Kontoyiannis, “Common community respiratory viruses in patients with cancer: more than just "common colds",” Cancer, vol. 97, no. 10, pp. 2576–2587, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. H. Wendt, J. M. K. Fox, and M. I. Hertz, “Paramyxovirus infection in lung transplant recipients,” Journal of Heart and Lung Transplantation, vol. 14, no. 3, pp. 479–485, 1995. View at Google Scholar · View at Scopus
  11. L. H. McCurdy, A. Milstone, and S. Dummer, “Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin,” Journal of Heart and Lung Transplantation, vol. 22, no. 7, pp. 745–753, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Uçkay, P. M. Gasche-Soccal, L. Kaiser et al., “Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy,” Journal of Heart and Lung Transplantation, vol. 29, no. 3, pp. 299–305, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. Ghosh, R. E. Champlin, S. A. Giralt et al., “Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin,” Bone Marrow Transplantation, vol. 25, no. 7, pp. 751–755, 2000. View at Google Scholar · View at Scopus
  14. D. A. Tsitsikas, H. Oakervee, J. D. Cavenagh, J. Gribben, S. G. Agrawal, and F. M. Mattes, “Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience,” British Journal of Haematology, vol. 146, no. 5, pp. 574–576, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. E. Whimbey, R. E. Champlin, J. A. England et al., “Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients,” Bone Marrow Transplantation, vol. 16, no. 3, pp. 393–399, 1995. View at Google Scholar · View at Scopus
  16. R. E. Champlin and E. Whimbey, “Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience,” Biology of Blood and Marrow Transplantation, vol. 7, no. 12, supplement, pp. 8S–10S, 2001. View at Google Scholar · View at Scopus
  17. F. S. de Fontbrune, M. Robin, R. Porcher et al., “Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation,” Clinical Infectious Diseases, vol. 45, no. 8, pp. 1019–1024, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. J. N. Shah and R. F. Chemaly, “Management of RSV infections in adult recipients of hematopoietic stem cell transplantation,” Blood, vol. 117, no. 10, pp. 2755–2763, 2011. View at Publisher · View at Google Scholar · View at PubMed
  19. M. G. Ison and M. G. Michaels, “RNA respiratory viral infections in solid organ transplant recipients,” American Journal of Transplantation, vol. 9, supplement 4, pp. S166–S172, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. A. R. Glanville, A. I. R. Scott, J. M. Morton et al., “Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation,” Journal of Heart and Lung Transplantation, vol. 24, no. 12, pp. 2114–2119, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. M. A. Gill and R. C. Welliver, “Motavizumab for the prevention of respiratory syncytial virus infection in infants,” Expert Opinion on Biological Therapy, vol. 9, no. 10, pp. 1335–1345, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus